Simplify Logo

Full-Time

Senior Scientist

Computational Biology

Confirmed live in the last 24 hours

Sana Biotechnology

Sana Biotechnology

201-500 employees

Develops engineered cell-based medical therapies

Biotechnology

Compensation Overview

$160k - $200kAnnually

Senior, Expert

Cambridge, MA, USA + 1 more

Category
Computational Biology
Genomics
Biology & Biotech
Required Skills
Python
Git
Requirements
  • PhD in computational biology, bioinformatics, genetics, or related discipline with up to 5+ years of industry experience (or MSc with 7+ years of industry experience)
  • Strong scientific background including an understanding of molecular biology and genomics
  • Familiarity with NGS platforms and hands-on experience with all steps for analyzing NGS data
  • Demonstrated proficiency in script languages such as Python and familiarity with a compiled language such as C/C++ or Java
  • Routine use of version control such as git
  • Experience with high performance computing
  • Demonstrated strong analytical skills and problem-solving
  • Be detail oriented, self-motivated and able to prioritize multiple projects concurrently
Responsibilities
  • Develop and optimize analysis workflows to analyze NGS data, including both whole genome sequencing (WGS/WES), targeted sequencing, and bulk/single cell RNA Seq
  • Develop novel Bioinformatics methods to answer platform and biological questions, and demonstrate validity of methods through prototypes and benchmarking using appropriate controls
  • Work with other computational biologists and computational engineers to deliver and optimize production-level pipelines
  • Proper documentation of code, workflows, and analyses including study reports for nonclinical and clinical studies and regulatory filings
  • Communicate to a broad audience with a range of technical, analytical, and biological expertise and present results on a regular basis at various group meetings

Sana Biotechnology specializes in utilizing engineered cells as medicines to address various diseases and developing novel delivery technologies to repair and control genes in cells. The company also focuses on enabling broader access to therapies through scalable manufacturing solutions.

Company Stage

IPO

Total Funding

$865M

Headquarters

Seattle, Washington

Founded

2018

Growth & Insights
Headcount

6 month growth

-1%

1 year growth

-16%

2 year growth

-16%